Download
s12876-021-01885-4.pdf 1,03MB
WeightNameValue
1000 Titel
  • Study protocol P-MAPS: microbiome as predictor of severity in acute pancreatitis—a prospective multicentre translational study
1000 Autor/in
  1. Ammer-Herrmenau, C. |
  2. Asendorf, T. |
  3. Beyer, G. |
  4. Buchholz, S. M. |
  5. Cameron, S. |
  6. Damm, M. |
  7. Frost, F. |
  8. Henker, R. |
  9. Jaster, R. |
  10. Phillip, V. |
  11. Placzek, M. |
  12. Ratei, C. |
  13. Sirtl, S. |
  14. van den Berg, T. |
  15. Weingarten, M. J. |
  16. Woitalla, J. |
  17. Mayerle, J. |
  18. Ellenrieder, V. |
  19. Neesse, A. |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-07-31
1000 Erschienen in
1000 Quellenangabe
  • 21(1):304
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12876-021-01885-4 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325304/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Acute pancreatitis (AP) is an inflammatory disorder that causes a considerable economic health burden. While the overall mortality is low, around 20% of patients have a complicated course of disease resulting in increased morbidity and mortality. There is an emerging body of evidence that the microbiome exerts a crucial impact on the pathophysiology and course of AP. For several decades multiple clinical and laboratory parameters have been evaluated, and complex scoring systems were developed to predict the clinical course of AP upon admission. However, the majority of scoring systems are determined after several days and achieve a sensitivity around 70% for early prediction of severe AP. Thus, continued efforts are required to investigate reliable biomarkers for the early prediction of severity in order to guide early clinical management of AP patients.!##!Methods!#!We designed a multi-center, prospective clinical-translational study to test whether the orointestinal microbiome may serve as novel early predictor of the course, severity and outcome of patients with AP. We will recruit 400 AP patients and obtain buccal and rectal swabs within 72 h of admission to the hospital. Following DNA extraction, microbiome analysis will be performed using 3rd generation sequencing Oxford Nanopore Technologies (ONT) for 16S rRNA and metagenomic sequencing. Alpha- and beta-diversity will be determined and correlated to the revised Atlanta classification and additional clinical outcome parameters such as the length of hospital stay, number and type of complications, number of interventions and 30-day mortality.!##!Discussion!#!If AP patients show a distinct orointestinal microbiome dependent on the severity and course of the disease, microbiome sequencing could rapidly be implemented in the early clinical management of AP patients in the future.!##!Trial registration!#!ClinicalTrials.gov Identifier: NCT04777812.
1000 Sacherschließung
lokal Metagenomic sequencing
lokal Prospective
lokal Study Protocol
lokal Hepatobiliary and pancreatic disorders
lokal Humans [MeSH]
lokal Prospective Studies [MeSH]
lokal Severity of Illness Index [MeSH]
lokal Severity
lokal RNA, Ribosomal, 16S/genetics [MeSH]
lokal Multicenter Studies as Topic [MeSH]
lokal P-MAPS
lokal Biomarker
lokal Acute Disease [MeSH]
lokal Microbiota [MeSH]
lokal Multicentric
lokal NCT04777812
lokal Prognosis [MeSH]
lokal Oxford nanopore technologies
lokal Acute pancreatitis
lokal Orointestinale microbiome
lokal Pancreatitis [MeSH]
lokal ONT
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/QW1tZXItSGVycm1lbmF1LCBDLg==|https://frl.publisso.de/adhoc/uri/QXNlbmRvcmYsIFQu|https://frl.publisso.de/adhoc/uri/QmV5ZXIsIEcu|https://frl.publisso.de/adhoc/uri/QnVjaGhvbHosIFMuIE0u|https://frl.publisso.de/adhoc/uri/Q2FtZXJvbiwgUy4=|https://frl.publisso.de/adhoc/uri/RGFtbSwgTS4=|https://frl.publisso.de/adhoc/uri/RnJvc3QsIEYu|https://frl.publisso.de/adhoc/uri/SGVua2VyLCBSLg==|https://frl.publisso.de/adhoc/uri/SmFzdGVyLCBSLg==|https://frl.publisso.de/adhoc/uri/UGhpbGxpcCwgVi4=|https://frl.publisso.de/adhoc/uri/UGxhY3playwgTS4=|https://frl.publisso.de/adhoc/uri/UmF0ZWksIEMu|https://frl.publisso.de/adhoc/uri/U2lydGwsIFMu|https://frl.publisso.de/adhoc/uri/dmFuIGRlbiBCZXJnLCBULg==|https://frl.publisso.de/adhoc/uri/V2VpbmdhcnRlbiwgTS4gSi4=|https://frl.publisso.de/adhoc/uri/V29pdGFsbGEsIEou|https://frl.publisso.de/adhoc/uri/TWF5ZXJsZSwgSi4=|https://frl.publisso.de/adhoc/uri/RWxsZW5yaWVkZXIsIFYu|https://frl.publisso.de/adhoc/uri/TmVlc3NlLCBBLg==
1000 Hinweis
  • DeepGreen-ID: d59ab7a4b5f7442da253162d191fed88 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6465642.rdf
1000 Erstellt am 2023-11-16T15:27:13.915+0100
1000 Erstellt von 322
1000 beschreibt frl:6465642
1000 Zuletzt bearbeitet 2023-12-01T02:50:38.771+0100
1000 Objekt bearb. Fri Dec 01 02:50:38 CET 2023
1000 Vgl. frl:6465642
1000 Oai Id
  1. oai:frl.publisso.de:frl:6465642 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source